These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246 [TBL] [Abstract][Full Text] [Related]
4. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma. Al-Shagahin H; Alkotyfan K; Müller HH; Sesterhenn AM; Werner JA Anticancer Res; 2009 Aug; 29(8):3421-5. PubMed ID: 19661367 [TBL] [Abstract][Full Text] [Related]
5. Comparison of CYFRA 21-1 and tissue polypeptide specific antigen (TPS) for detecting nasopharyngeal carcinoma. Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH Anticancer Res; 2002; 22(6B):3793-6. PubMed ID: 12552995 [TBL] [Abstract][Full Text] [Related]
6. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis? Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706 [TBL] [Abstract][Full Text] [Related]
7. [A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]. Ychou M; Khemissa-Akouz F; Kramar A; Senesse P; Grenier J Bull Cancer; 2001 Oct; 88(10):1023-7. PubMed ID: 11713038 [TBL] [Abstract][Full Text] [Related]
8. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer. Suzuki H; Ishikawa S; Satoh H; Ishikawa H; Sakai M; Yamamoto T; Onizuka M; Sakakibara Y Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649 [TBL] [Abstract][Full Text] [Related]
9. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Nagler RM; Barak M; Peled M; Ben-Aryeh H; Filatov M; Laufer D Cancer; 1999 Mar; 85(5):1018-25. PubMed ID: 10091783 [TBL] [Abstract][Full Text] [Related]
10. Preoperative serum CYFRA 21-1 level as a prognostic factor in surgically treated adenocarcinoma of lung. Park SY; Lee JG; Kim J; Park Y; Lee SK; Bae MK; Lee CY; Kim DJ; Chung KY Lung Cancer; 2013 Feb; 79(2):156-60. PubMed ID: 23206831 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer. Bonfrer JM; Gaarenstroom KN; Kenter GG; Korse CM; Hart AA; Gallee MP; Helmerhorst TJ; Kenemans P Gynecol Oncol; 1994 Dec; 55(3 Pt 1):371-5. PubMed ID: 7530676 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients. Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324 [TBL] [Abstract][Full Text] [Related]
13. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response. Vollmer RT; Govindan R; Graziano SL; Gamble G; Garst J; Kelley MJ; Christenson RH Clin Cancer Res; 2003 May; 9(5):1728-33. PubMed ID: 12738727 [TBL] [Abstract][Full Text] [Related]
14. Cyfra 21-1 as a tumor marker for follow-up of patients with squamous cell carcinoma of the oropharynx. Alkotyfan K; Wiegand S; Müller HH; Windfuhr JP; Werner JA; Sesterhenn AM Anticancer Res; 2010 Jun; 30(6):2291-6. PubMed ID: 20651382 [TBL] [Abstract][Full Text] [Related]
15. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma. Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276 [TBL] [Abstract][Full Text] [Related]
16. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen. Tsai SC; Kao CH; Wang SJ Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956 [TBL] [Abstract][Full Text] [Related]
17. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer. Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease. Doweck I; Barak M; Uri N; Greenberg E Br J Cancer; 2000 Dec; 83(12):1696-701. PubMed ID: 11104568 [TBL] [Abstract][Full Text] [Related]
19. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation. Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326 [TBL] [Abstract][Full Text] [Related]
20. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer. Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]